Keitaro Mashimo1, Ayumi Usui-Ouchi1, Yousuke Ito1, Rei Wakasa-Arai1, Norihiko Yokoi2, Satoshi Kawasaki3, Akira Murakami4, Akira Matsuda4, Nobuyuki Ebihara5. 1. Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, Japan. 2. Department of Ophthalmology, Kyoto Prefectural University School of Medicine, Kyoto, Japan. 3. Department of Ophthalmology, Osaka University School of Medicine, Osaka, Japan. 4. Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan. 5. Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, Japan. ebihara@juntendo.ac.jp.
Abstract
PURPOSE: Vernal keratoconjunctivitis (VKC) is a severe and recurrent allergic conjunctivitis, the mechanism of which is not well understood. In this study, we investigated the role of oncostatin M (OSM) in the pathogenesis of VKC, with a focus on tissue remodeling. STUDY DESIGN: Clinical and experimental. PATIENTS AND METHODS: The OSM concentrations in tear fluid samples obtained from VKC patients and healthy controls were measured using ELISA, and the expression of OSM mRNA and protein in giant papillae resected from VKC patients was investigated using RT-PCR and immunohistochemistry, respectively. In cultured human conjunctival epithelial cells (HconEpiCs), expression of OSM receptor β (OSMRβ) was detected using immunocytochemical and FACS analyses. Finally, we investigated whether recombinant OSM activated STAT1 and STAT3 to induce the expression of various genes related to tissue remodeling in HconEpiCs, by using Western blot analysis, microarray analysis, and RT-PCR. RESULTS: The OSM concentration was higher in the tear fluid of VKC patients than in that of the healthy controls, and strong expression of OSM mRNA was found in the giant papillae. We also detected T cells expressing OSM in the giant papillae. In addition, HconEpiCs showed surface expression of OSMRβ. Recombinant human OSM strongly activated both STAT1 and STAT3 in HconEpiCs and induced various tissue remodeling-related genes, including MMP-1, MMP-3, IL-24, IL-20, serpinB3, S100A7, tenascin C, and SOCS3. CONCLUSION: Our results suggest that OSM is one of the key molecules involved in remodeling of giant papillae in VKC.
PURPOSE:Vernal keratoconjunctivitis (VKC) is a severe and recurrent allergic conjunctivitis, the mechanism of which is not well understood. In this study, we investigated the role of oncostatin M (OSM) in the pathogenesis of VKC, with a focus on tissue remodeling. STUDY DESIGN: Clinical and experimental. PATIENTS AND METHODS: The OSM concentrations in tear fluid samples obtained from VKC patients and healthy controls were measured using ELISA, and the expression of OSM mRNA and protein in giant papillae resected from VKC patients was investigated using RT-PCR and immunohistochemistry, respectively. In cultured human conjunctival epithelial cells (HconEpiCs), expression of OSM receptor β (OSMRβ) was detected using immunocytochemical and FACS analyses. Finally, we investigated whether recombinant OSM activated STAT1 and STAT3 to induce the expression of various genes related to tissue remodeling in HconEpiCs, by using Western blot analysis, microarray analysis, and RT-PCR. RESULTS: The OSM concentration was higher in the tear fluid of VKC patients than in that of the healthy controls, and strong expression of OSM mRNA was found in the giant papillae. We also detected T cells expressing OSM in the giant papillae. In addition, HconEpiCs showed surface expression of OSMRβ. Recombinant human OSM strongly activated both STAT1 and STAT3 in HconEpiCs and induced various tissue remodeling-related genes, including MMP-1, MMP-3, IL-24, IL-20, serpinB3, S100A7, tenascin C, and SOCS3. CONCLUSION: Our results suggest that OSM is one of the key molecules involved in remodeling of giant papillae in VKC.
Entities:
Keywords:
Conjunctival epithelial cells; Oncostatin M; T cells; Tissue remodeling; Vernal keratoconjunctivitis
Authors: Dominik K Fritz; Christine Kerr; Ramzi Fattouh; Alba Llop-Guevara; Waliul I Khan; Manel Jordana; Carl D Richards Journal: J Immunol Date: 2010-12-15 Impact factor: 5.422
Authors: Afsaneh Mozaffarian; Avery W Brewer; Esther S Trueblood; Irina G Luzina; Nevins W Todd; Sergei P Atamas; Heather A Arnett Journal: J Immunol Date: 2008-11-15 Impact factor: 5.422
Authors: Amelia K Scaffidi; Steven E Mutsaers; Yuben P Moodley; Robin J McAnulty; Geoffrey J Laurent; Philip J Thompson; Darryl A Knight Journal: Br J Pharmacol Date: 2002-07 Impact factor: 8.739